Sign inJoin waitlistJoin the waitlist

Adriana Rossi

Director of CART and the Stem Cell Transplant Clinical Service at the Center of Excellence for Multiple Myeloma · Icahn School of Medicine at Mount Sinai

Credentials: · ·

History

Clinical Program Manager · Icahn School of Medicine at Mount Sinai
Present
Icahn School of Medicine at Mount Sinai
Present

Weill Cornell Medical College
2010–2013
Internal Medicine
Thomas Jefferson University Hospital
2007–2010
M.H.S., The Johns Hopkins University, 2002
George Washington University Medical School
2003–2007
University of Michigan
1994–1998

Research

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
Blood Cancer Discovery · 2023 · 129 citations
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology · 2025 · 113 citations
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Blood · 2023 · 95 citations

Shambavi Richard
27 papers
Joshua Richter
20 papers
Sundar Jagannath
20 papers
Samir Parekh
19 papers
Cesar Valdes
17 papers
Roger Pearse
17 papers
Hearn Cho
16 papers
Larysa Sanchez
16 papers
Ruben Niesvizky
16 papers
Santiago Thibaud
16 papers
Ajai Chari
15 papers
TM
Tomer Mark
15 papers

Clinical trials

ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Principal investigator · Terminated · Phase 1, Phase 2
Adriana Rossi
2024–2025
Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)
Principal investigator · Terminated · Phase 2
Weill Medical College of Cornell University
2018–2020
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Site PI · Recruiting · Phase 1
Caribou Biosciences, Inc.
2023–2027